Contact Us

 

HEADQUATERS ADDRESS

14F, 26, Samseong-ro 85-gil, Gangnam-gu, Seoul, 

Republic of Korea

BUNDANG OFFICE ADDRESS

28, Yatap-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 

Republic of Korea

SALES TEAM

biz@bbbtech.com

International (English) : +82-70-4407-8808

OTHER QUESTIONS

contact@bbbtech.com

International (Korean) : +82-2-565-9653

Products
Company
Careers

BBB inc. ©2019        

WELCOME TO THE NEW GENERATION

OF POCT

Quantitative immunoassay biosensor

to diagnosis cancer, cardiovascular diseases, sepsis, infectious diseases, thyroid disorders.

Easy, Quick, Accurate

• Deliver lab-quality results

• Connected to anywhere

• Reduces the complexity

• Shorten time to diagnosis

• No matter where the testing takes place

19cm

Focuses on

the purpose of

POCT

Fully automated analysis

Once inserted into the instrument, the sample is separated into plasma by our patent technology.

In succession, the electrochemical analysis process begins.

No need  for pre-processing 

Self-contained consumable

Quick turnaround 3~10min

Quantify precisely

by electrochemical method

MARK-B utilizes MESIA, a patented technology of BBB inc.

Published Journal Paper

“MESIA: Magnetic force-assisted electrochemical sandwich immunoassays for quantification of prostate-specific antigen in human serum” 

_ <Analytica Chimica Acta>, March, 2019

_ PhD. Hyundoo Hwang, Leader of BBB R&D Center

High expandability in test portfolio 

TUMOR

AFP    PSA    CEA    CA19-9    CA125

CARDIOVASCULAR

DISEASES

cTnI    CK-MB    Myoglobin    D-dimer

hsCRP    NT-proBNP    Gal-3    ST2

SEPSIS

PCT    IL-6   CRP

INFECTIOUS DISEASES

DVNS1    Influenza A    Influenza B

THYROID

TSH    T3    T4

METABOLISM

VitaminD    Ferritin

ALZHEIMER'S DISEASES

β-amyloid    τ protein    NfL

*Not available for sale

*Scheduled to release in 2020

Connectivity!

Cloud server to communicate with MARK-B test results

POCT1-A2 protocol,  HL7, FHIR® to communicate with DMS

Android 7.0-based Analyzer software